tirzepatide legal battle Eli Lilly Files Slew of Lawsuits Over Zepbound and Mounjaro Weight-loss drug tirzepatide may lower

Mild to moderate nausea or transient feelings of stomach fullness as your digestive speed re-aligns

In the closely watched trial, known as Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity (SELECT), more than 17,000 people who were considered overweight or had obesity and who had cardiovascular disease but not diabetes took either semaglutide or a placebo for an average of nearly three years

While very rare, rapid weight loss can occasionally contribute to gallstone formation

But contrary to the prevailing narrative, healthy fat is one of your biggest allies when it comes to GLP-1

Disclaimer For laboratory research use only